TheCapTable
Subscribe

Stories

About Us

Home

Stories

Explore

Sign In

Stories

About Us
HealthTech

Why FDA certification is the new moat in India's MedTech race

FDA approval has become Indian MedTech's credibility passport, and its most significant barrier. With costs reaching $5 million and timelines stretching years, only well-funded startups can afford the journey from Bengaluru labs to global hospital systems.

Why FDA certification is the new moat in India's MedTech race

Latest

Newsletter illustration

Sign up to Our Newsletter

Get a glimpse of our unique and insightful stories delivered straight to your inbox.

CT Capsule

Weekly key news & insights from The CapTable.

How Blinkit turned stationery from fringe to a fast-moving ₹500 Cr+ category
Quick Commerce

How Blinkit turned stationery from fringe to a fast-moving ₹500 Cr+ category

From pens, pencils and copier sheets to bulk art kits and diaries, Blinkit has made stationery a fast-moving, impulse-driven category and central to India’s $13.2-billion paper and stationery market. Monthly sales cross Rs 40 crore, metros dominate, and brands like DOMS, ITC & Uniball are cashing in

Sohini MitterBy Sohini Mitter

Startups

Track India's startups from seed to growth.

Patent pending: Why Indian startups aren't racing to protect IP

Policy

Patent pending: Why Indian startups aren't racing to protect IP

While India celebrated a record year of patent approvals in 2023, a severe shortage of patent agents and examiners, coupled with lengthy processing times and weak enforcement, continues to hold back the country's intellectual property ambitions.

E-Commerce
See All
FinTech
See All
Big Tech
See All
Other Categories